Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Final Generic Abuse-Deterrent Opioids Guidance Coming This Year

May 31 2017

• By Derrick Gingery

pills

Related Content

Abuse-Deterrent Opioids: Postmarketing Data Eyed As Development ‘Anchor’

Apr 13 2017

Opioid Policy At US FDA: Gottlieb Seeks More Activist Role To Combat Abuse

Apr 07 2017

Gottlieb Becomes US FDA Commissioner With Immediate Issues Pending

May 10 2017

Abuse Deterrence: US Exclusivity Update May Ride User Fee Coattails

Mar 28 2017

FDA's Opioid Action Plan Could Clear Califf Nomination Roadblock

Feb 04 2016

Abuse-Deterrent Opioids Could Gain Significant First-Mover Advantage Under FDA Guidance

Apr 02 2015

Generic Abuse Deterrent Opioids: FDA Offers Tier-Based Testing Approach

Mar 24 2016

Abuse-Deterrent Opioids: FDA Advocates Joint Brand-Generic Development Plan

Nov 03 2016

Generics Of Abuse-Deterrent Opioids Will Get FDA Guidance, Eventually

Oct 07 2013

Related Companies

Cipla Limited

Additional Topics

United States Drug Approval Standards Generic Drugs Regulation FDA Research & Development BioPharmaceutical

More from Generics

More from Products

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window